Following a series of FOI requests to CCGs, MTG said a number of CCGs are currently restricting acce...
Read moreNHS England’s cost-effectiveness watchdog, (NICE), issued a first draft document saying that it di...
Read moreFaster access to new treatments for very rare conditions announced following a revised decision maki...
Read moreThe development of gene therapies represents a new frontier of science, with the potential to help p...
Read moreThis study investigates the efficiency of the new CDF appraisal process for indications without prio...
Read moreThis study investigates NICE's evaluation of existing CDF treatments and its potential impact on fun...
Read moreFrom July 2016 NICE will gain decision power by saying yes, no or maybe to cancer drugs entering the...
Read morePharmaceutical companies are able to charge significantly higher prices as these products are addres...
Read moreNew legislation has enabled AIFA to approve reimbursement for Avastin for off-label usage in the tre...
Read moreUpdates on the latest news on NICE's Value Based Assessment, as well as the approval of ultra-orphan...
Read more